Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“I am going to apologize in advance. I can’t help myself but will take the opportunity to provide a long dissertation on the history and strategy of the development of a cancer vaccine at ImmunityBio starting as far back as 2017.
I will also provide detailed information as to the mechanism of action, both of Anktiva as the backbone as well as the combination of Anktiva with the product pipeline of ImmunityBio to develop the Cancer BioShield platform.
I know this will be long but it is the annual report of a decades worth of work. I will try to provide a slide deck ahead of the discussion tomorrow.”
Other articles featuring Patrick Soon-Shiong on OncoDaily.